You are here

Healthcare Economics


Medtronic agreed to acquire HeartWare International Inc. on June 27 for approximately $1.1 billion.



Recent Headlines

With Abbott deal near completion, St. Jude Medical’s sales increase 11%

Led by strong sales growth in its atrial fibrillation and heart failure divisions, St. Jude Medical’s second quarter sales increased 11 percent to $1.56 billion compared with the same period last year. The quarter ended July 2.

Abbott’s revenue increases 3.2% in second quarter

For the second quarter of fiscal year 2016, Abbott’s sales increased 3.2 percent to $5.33 billion, while its net earnings decreased 21.5 percent compared with the same period of 2015.

Madrigal, Synta complete merger

Madrigal Pharmaceuticals and Synta Pharmaceuticals completed their merger on July 22.

Theranos hires executives, creates committee to oversee regulatory compliance

Theranos hired Dave Wurtz and Daniel Guggenheim on July 21 to lead the beleaguered company’s regulatory, quality and compliance departments.

Novartis plans to invest $200 million this year to increase sales of heart failure medication

Novartis plans on spending an additional $200 million this year to boost sales of sacubitril/valsartan (Entresto), the company’s twice-daily oral medication to treat patients with heart failure.

Mednax acquires Pediatric Cardiology Associates in cash deal

Mednax acquired Pediatric Cardiology Associates on July 11 in a cash transaction for an undisclosed amount.

CMS sanctions Theranos, prohibits CEO from operating a lab for two years

The Centers for Medicare & Medicaid Services (CMS) revoked Theranos’ certification for a blood testing laboratory in California and prohibited the embattled company’s CEO Elizabeth Holmes from owning, operating or directing a laboratory for at least two years.

Policy experts ask HHS to test bundled payments for cardiac procedures

A coalition of physicians, health policy experts and interest groups called on HHS to set up more mandatory pilot programs to test out bundled payment models within Medicare.

Chiesi completes acquisition of cardiovascular medications from The Medicines Company

The Medicines Company completed its divestiture of three cardiovascular medications to Chiesi USA, Inc. on June 21, one month after the companies agreed to the deal.

Medtronic raises quarterly cash dividend by 13%

Medtronic raised its quarterly cash dividend 13 percent on June 24 to $0.43 per ordinary share.